Doximity Shares Outstanding 2020-2024 | DOCS
Doximity shares outstanding history from 2020 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Doximity shares outstanding for the quarter ending March 31, 2024 were 0.201B, a 5.77% decline year-over-year.
- Doximity 2024 shares outstanding were 0.206B, a 3.6% decline from 2023.
- Doximity 2023 shares outstanding were 0.213B, a 11.73% increase from 2022.
- Doximity 2022 shares outstanding were 0.191B, a 100.79% increase from 2021.
| Doximity Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 206 |
| 2023 | 213 |
| 2022 | 191 |
| 2021 | 95 |
| 2020 | 82 |
| 2019 | 76 |
| Doximity Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-03-31 | 201 |
| 2023-12-31 | 200 |
| 2023-09-30 | 209 |
| 2023-06-30 | 212 |
| 2023-03-31 | 213 |
| 2022-12-31 | 212 |
| 2022-09-30 | 214 |
| 2022-06-30 | 215 |
| 2022-03-31 | 191 |
| 2021-12-31 | 216 |
| 2021-09-30 | 217 |
| 2021-06-30 | 115 |
| 2021-03-31 | 95 |
| 2020-12-31 | 100 |
| 2020-09-30 | 92 |
| 2020-06-30 | 85 |
| 2020-03-31 | |
| 2019-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $5.034B | $0.475B |
| Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.295B | 15.60 |
| Cencora (COR) | United States | $47.007B | 18.33 |
| ICON (ICLR) | Ireland | $26.068B | 24.61 |
| DiDi Global (DIDIY) | China | $21.483B | 0.00 |
| Avantor (AVTR) | United States | $14.638B | 21.55 |
| CochLear (CHEOY) | Australia | $14.016B | 0.00 |
| Revvity (RVTY) | United States | $13.265B | 23.27 |
| Natera (NTRA) | United States | $13.164B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.413B | 40.84 |
| Viatris (VTRS) | United States | $12.216B | 3.65 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.939B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.798B | 20.67 |
| Solventum (SOLV) | United States | $9.292B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.560B | 0.00 |
| HealthEquity (HQY) | United States | $7.157B | 45.96 |
| Bausch + Lomb (BLCO) | Canada | $5.309B | 21.25 |
| Organon (OGN) | United States | $5.259B | 4.99 |
| PACS (PACS) | United States | $4.404B | 0.00 |
| Life Times (LTH) | United States | $3.653B | 38.27 |
| Sotera Health (SHC) | United States | $3.278B | 16.08 |
| Surgery Partners (SGRY) | United States | $3.011B | 27.55 |
| GoodRx Holdings (GDRX) | United States | $2.927B | 111.43 |
| Agilon Health (AGL) | United States | $2.612B | 0.00 |
| Progyny (PGNY) | United States | $2.413B | 41.54 |
| NovoCure (NVCR) | Jersey | $2.063B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.019B | 8.00 |
| Premier (PINC) | United States | $1.914B | 8.19 |
| BrightSpring Health Services (BTSG) | United States | $1.785B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.637B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.356B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.176B | 0.00 | |
| CareDx (CDNA) | United States | $0.728B | 0.00 |
| Embecta (EMBC) | United States | $0.719B | 4.89 |
| GeneDx Holdings (WGS) | United States | $0.703B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.649B | 6.88 |
| InnovAge Holding (INNV) | United States | $0.619B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.594B | 0.00 |
| Enhabit (EHAB) | United States | $0.442B | 44.05 |
| QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.432B | 0.00 |
| ModivCare (MODV) | United States | $0.370B | 6.93 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| DocGo (DCGO) | United States | $0.313B | 17.11 |
| LifeMD (LFMD) | United States | $0.300B | 0.00 |
| Sharecare (SHCR) | United States | $0.281B | 0.00 |
| MultiPlan (MPLN) | United States | $0.247B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.232B | 0.00 |
| Beauty Health (SKIN) | United States | $0.219B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.189B | 0.00 |
| Biodesix (BDSX) | United States | $0.185B | 0.00 |
| So-Young (SY) | China | $0.111B | 53.55 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.045B | 0.00 |
| NeueHealth (NEUE) | United States | $0.043B | 5.83 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Oncology Institute (TOI) | United States | $0.031B | 0.00 |
| Nutex Health (NUTX) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.024B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| KindlyMD (KDLY) | $0.017B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.001B | 0.00 |